ESG in action for Pharma

5 opportunities to go beyond environmental responsibility

Rethinking sustainability in Pharma

Sustainability in pharma is more than reducing emissions and waste—it’s about creating lasting value for people, the planet, and business. This whitepaper highlights five essential pillars to help pharma companies move beyond environmental responsibility: healthcare equity, ethical and transparent supply chains, corporate social responsibility, governance, and impactful innovation.

Discover practical strategies to navigate tightening regulations, integrate ESG into core business practices, and partner with sustainability-aligned suppliers. Learn how initiatives like Verilege™ and dsm-firmenich’s proprietary tools can help your organization measure impact, improve transparency, and deliver sustainable solutions.

Whether your goal is to build trust with stakeholders, enhance corporate resilience, or foster innovation that benefits patients and communities, this guide provides the insights needed to make meaningful, measurable progress.

1. EurEau. Urban waste water treatment directive. https://www.eureau.org/priorites/urban-waste-water-treatment-directive

2. European Commission. Packaging waste. https://environment.ec.europa.eu/topics/waste-and-recycling/packaging-waste_en

3. European Commission. Zero Pollution: Modernised rules on industrial and livestock rearing emissions come into effect. https:// environment.ec.europa.eu/news/revised-industrial-emissions-directive-comes-effect-2024-08-02_en

4. ESG and Global Investor Returns Study, 2023. https://www.kroll.com/en/reports/cost-of-capital/esg-global-investor-returns-study

Related content

Related articles

  • Elevating patient care with smart science and superior services

    Elevating patient care with smart science and superior services

    Explore how dsm-firmenich can help pharma raise the bar in patient-centricity and sustainability.

  • Ask-the-expert: What’s next for pharma regulations in Asia-Pacific?

    Ask-the-expert: What’s next for pharma regulations in Asia-Pacific?

    Discover the top 5 trends transforming pharma regulations in Asia-Pacific and how drug developers can navigate this evolving landscape with dsm-firmenich.

  • dsm-firmenich’s API portfolio elevated by Verilege™

    dsm-firmenich’s API portfolio elevated by Verilege™

    Simplify the drug approvals process with Verilege™, an expert services platform offering regulatory, quality, sustainability, and supply chain support for APIs.

How can we help you?

  • New partnership request

    Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.